GIGYF2 Protein (GRB10-Interacting GYF Protein 2)

GIGYF2 Protein (GRB10-Interacting GYF Protein 2)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GIGYF2 Protein (GRB10-Interacting GYF Protein 2)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>GRB10-Interacting GYF Protein 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GIGYF2</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>Periplakin, NID2-associated protein, GRB10IP2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>5q33.1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UHQ2</td>
</tr>
<tr>
<td class="label">Entrez Gene ID</td>
<td>26060</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>2232 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~254 kDa</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>GYF domain family, adaptor proteins</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Amino Acids</td>
</tr>
<tr>
<td class="label">N-terminal region</td>
<td>1-200</td>
</tr>
<tr>
<td class="label">GYF domain</td>
<td>200-280</td>
</tr>
<tr>
<td class="label">Coiled-coil regions</td>
<td>300-800</td>
</tr>
<tr>
<td class="label">C-terminal region</td>
<td>1800-2232</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Receptor stabilization</td>
<td>Binds to insulin receptor</td>
</tr>
<tr>
<td

GIGYF2 Protein (GRB10-Interacting GYF Protein 2)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GIGYF2 Protein (GRB10-Interacting GYF Protein 2)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>GRB10-Interacting GYF Protein 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GIGYF2</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>Periplakin, NID2-associated protein, GRB10IP2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>5q33.1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UHQ2</td>
</tr>
<tr>
<td class="label">Entrez Gene ID</td>
<td>26060</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>2232 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~254 kDa</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>GYF domain family, adaptor proteins</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Amino Acids</td>
</tr>
<tr>
<td class="label">N-terminal region</td>
<td>1-200</td>
</tr>
<tr>
<td class="label">GYF domain</td>
<td>200-280</td>
</tr>
<tr>
<td class="label">Coiled-coil regions</td>
<td>300-800</td>
</tr>
<tr>
<td class="label">C-terminal region</td>
<td>1800-2232</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Receptor stabilization</td>
<td>Binds to insulin receptor</td>
</tr>
<tr>
<td class="label">Signal modulation</td>
<td>scaffolds downstream effectors</td>
</tr>
<tr>
<td class="label">Receptor internalization</td>
<td>Regulates endocytosis</td>
</tr>
<tr>
<td class="label">Degradation</td>
<td>Targets receptors for disposal</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High</td>
</tr>
<tr>
<td class="label">Pancreas</td>
<td>High</td>
</tr>
<tr>
<td class="label">Muscle</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Adipose</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Finding</td>
<td>Evidence</td>
</tr>
<tr>
<td class="label">Genetic association</td>
<td>GWAS hits at GIGYF2 locus</td>
</tr>
<tr>
<td class="label">Risk variants</td>
<td>Multiple SNPs associated</td>
</tr>
<tr>
<td class="label">Expression changes</td>
<td>Altered in PD brains</td>
</tr>
<tr>
<td class="label">Functional studies</td>
<td>Affects α-synuclein toxicity</td>
</tr>
<tr>
<td class="label">Disorder</td>
<td>GIGYF2 Role</td>
</tr>
<tr>
<td class="label">Type 2 diabetes</td>
<td>Insulin signaling modifier</td>
</tr>
<tr>
<td class="label">Obesity</td>
<td>Metabolic regulation</td>
</tr>
<tr>
<td class="label">Insulin resistance</td>
<td>Receptor trafficking</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">GRB10</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">IRS1/2</td>
<td>Adapter</td>
</tr>
<tr>
<td class="label">PI3K</td>
<td>Regulatory</td>
</tr>
<tr>
<td class="label">Shc</td>
<td>Adapter</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">rs37370</td>
<td>SNP</td>
</tr>
<tr>
<td class="label">rs247261</td>
<td>SNP</td>
</tr>
<tr>
<td class="label">rs124564</td>
<td>SNP</td>
</tr>
<tr>
<td class="label">Various</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Enhance function</td>
</tr>
<tr>
<td class="label">Peptides</td>
<td>Block interactions</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Restore expression</td>
</tr>
<tr>
<td class="label">Combination</td>
<td>Multi-target</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">GRB10</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">IRS1</td>
<td>Adapter</td>
</tr>
<tr>
<td class="label">PI3K</td>
<td>Regulatory</td>
</tr>
<tr>
<td class="label">EGF receptor</td>
<td>Binding</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a></td>
</tr>
</table>

GIGYF2 (GRB10-Interacting GYF Protein 2), also known as Periplakin or NID2 associated, is a large adaptor protein that serves as a critical node in growth factor and insulin signaling networks. The protein contains multiple protein-protein interaction domains that enable it to scaffold signaling complexes and regulate receptor tyrosine kinase trafficking. GIGYF2 has emerged as a significant player in neurodegenerative diseases, with genetic variants associated with increased risk for Parkinson's disease and Alzheimer's disease. [@song2021]

Domain Architecture

Structural Organization

GIGYF2 contains multiple functional domains:

GYF Domain

The GYF (glycine-tyrosine-phenylalanine) domain is a specialized protein interaction module:

• Recognition sequence: Proline-rich motifs (PXXP)
• Binding specificity: Multiple proline-rich proteins
• Structural fold: Unique α-helical fold
• Conservation: Present in several adaptor proteins

Proline-Rich Regions

Multiple proline-rich regions throughout the protein:

• SH3 binding sites: Enable interactions with Src family kinases
• WW domain binding: Potential for additional interactions
• Flexible linkers: Allow multi-valent interactions

Biological Functions

Insulin and IGF-1 Signaling

GIGYF2 is a key regulator of insulin receptor signaling:

Growth Factor Signaling

Beyond insulin, GIGYF2 modulates:

• EGF receptor signaling: Modulates EGFR trafficking
• PDGF signaling: Affects PDGF receptor function
• NGF signaling: Regulates neurotrophic factor signaling
• FGF signaling: Modulates FGFR pathways

Receptor Tyrosine Kinase Trafficking

GIGYF2 regulates receptor dynamics:

Neuronal Functions

In the nervous system, GIGYF2 participates in:

• Neuronal survival: Anti-apoptotic signaling
• Synaptic function: Regulates postsynaptic receptors
• Axonal transport: May affect trafficking in neurons
• Neuroprotection: Links growth factor signaling to survival

Expression and Distribution

Tissue Expression

Subcellular Localization

• Plasma membrane: Receptor interaction
• Cytoplasm: Scaffolding functions
• Endosomes: Receptor trafficking
• Golgi: Processing and sorting

Disease Associations

Parkinson's Disease

GIGYF2 has been linked to Parkinson's disease risk:

Alzheimer's Disease

GIGYF2 in AD:

• Genetic linkage: Some studies show association
• Aβ effects: GIGYF2 expression affected by Aβ
• Tau pathology: Linked to tau phosphorylation
• Therapeutic potential: Target for intervention

Metabolic Disorders

Cancer

• Oncogenic potential: Altered in some cancers
• Receptor signaling: Modulates growth factor pathways
• Therapeutic target: Potential for modulation

Molecular Mechanisms

Signaling Complex Formation

GIGYF2 scaffolds signaling complexes:

Interaction Partners

Regulatory Mechanisms

• Phosphorylation: Modulates adaptor function
• Ubiquitination: Controls protein stability
• Alternative splicing: Generates isoforms
• Cellular localization: Affects function

Genetics

Disease-Associated Variants

GWAS Findings

Genome-wide association studies have identified:

• Parkinson's disease: Multiple signals at 5q33.1
• Type 2 diabetes: Some association
• Alzheimer's: Modest signals
• Height: Some associations

Therapeutic Implications

Drug Development

Challenges

• Complex multi-functional protein
• Tissue-specific functions
• Balancing multiple pathways
• Delivery to CNS

Interaction Network

Signaling Pathways

• Insulin receptor pathway: Primary pathway
• IGF-1 signaling: Growth factor signaling
• PI3K/Akt pathway: Cell survival
• MAPK pathway: Proliferation

Protein-Protein Interactions

Animal Models

Knockout Studies

• Gigyf2-/- mice: Embryonic lethal
• Heterozygotes: Metabolic phenotypes
• Conditional: Tissue-specific knockouts

Disease Models

• Parkinson's models: Cross with α-synuclein mice
• Metabolic models: Insulin resistance studies
• Behavioral: Learning and memory

Research Methods

Biochemical Approaches

• Co-immunoprecipitation: Interaction detection
• Mass spectrometry: Complex identification
• Phosphorylation analysis: Pathway mapping
• Ubiquitination studies: Degradation mechanisms

Cellular Studies

• Live cell imaging: Receptor trafficking
• FRET: Protein interactions
• Flow cytometry: Receptor expression
• Functional assays: Signaling output

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

Summary

GIGYF2 is a large adaptor protein that serves as a critical node in insulin and growth factor signaling networks. Through its multiple protein-protein interaction domains, GIGYF2 scaffolds signaling complexes and regulates receptor tyrosine kinase trafficking, affecting cellular responses to insulin, IGF-1, and other growth factors. Genetic variants in GIGYF2 are associated with increased risk for Parkinson's disease and Alzheimer's disease, highlighting its importance in neuronal health and disease. Understanding GIGYF2's role in receptor signaling and neurodegeneration offers potential therapeutic strategies for metabolic and neurological disorders.

References